Sex is a major determinant of CYP3A4 expression in human liver.
about
Genetic predictors of interindividual variability in hepatic CYP3A4 expressionMuscular effects of statins in the elderly female: a reviewFemale-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesMetabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolismTranscriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery diseasePerinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspringQualitative de novo analysis of full length cDNA and quantitative analysis of gene expression for common marmoset (Callithrix jacchus) transcriptomes using parallel long-read technology and short-read sequencingRole of TRPA1 in Acute Cardiopulmonary Toxicity of Inhaled AcroleinStatins in Primary Prevention: Uncertainties and Gaps in Randomized Trial Data.Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR).Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3Statins are related to impaired exercise capacity in males but not females.Human liver expression of CYP2C8: gender, age, and genotype effects.A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytes.Evaluation of sexual dimorphism in the efficacy and safety of simvastatin/atorvastatin therapy in a southern Brazilian cohort.Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.Toxicity Profile of the Aqueous Ethanol Root Extract of Corrigiola telephiifolia Pourr. (Caryophyllaceae) in Rodents.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expressionCytochrome P450 and xenobiotic receptor humanized mice.Functional interactions between P-glycoprotein and CYP3A in drug metabolism.Sex differences in drug disposition.Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosisPathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice.Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men.Sex differences in the effectiveness of statins after myocardial infarction.Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugsGender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapyLack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort.Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.Disruption of STAT5b-Regulated Sexual Dimorphism of the Liver Transcriptome by Diverse Factors Is a Common EventSex-specific mouse liver gene expression: genome-wide analysis of developmental changes from pre-pubertal period to young adulthood.Gender-specific induction of cytochrome P450s in nonylphenol-treated FVB/NJ miceDifferential effects of clinically used derivatives and metabolites of artemisinin in the activation of constitutive androstane receptor isoformsGender-specific differences in hypothalamus-pituitary-adrenal axis activity during childhood: a systematic review and meta-analysis.Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias.Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.Clinical implications of CYP3A polymorphisms.
P2860
Q24631001-62027870-EC72-4B58-A5D1-0120EE93049CQ27023343-6CA02A7A-5CB2-4A8D-8E19-4A19C1D79C1BQ28182631-B772287A-4DE1-4F25-9C10-2028D52F8A83Q28476513-3D291A7F-4966-4BBF-AFC0-B7F19B4DF2B9Q28476544-E35362E9-5AF1-40C9-8B3F-ACEC70ADEEB9Q28539372-A3FD2724-C3D4-405B-B887-1C04D50085BDQ28540182-AE13C46D-D577-4393-ADCA-382CD2D0B9EDQ29248707-ABE77714-8AFF-4B96-971E-E27F46A44DA3Q31133434-EB77D191-A2C2-455C-A835-68261705BB24Q33559832-946DA64F-7B30-474B-A9A5-C8ED2FCC3F48Q33710324-5AD7C984-156A-4633-93E8-A07036E96C25Q33803252-A6880E6E-42DB-4520-BC15-1AE1708C7BE6Q33891033-D534849E-4644-4CA0-8C57-63937D05A7EAQ33891588-681D5C99-2B87-4318-8B56-ABF118170C8EQ34020658-686AA447-C1E4-4C16-B1FD-81ECFE91EE4CQ34149359-96329B79-B9BB-4660-8A63-3B7E09349830Q34186833-18CD085A-4349-453F-A4EC-A9D1FC57A3EBQ34204238-DBA5C4EF-E8B4-4A12-84B4-65C9197D48DBQ34291146-5B304315-4207-4793-8403-776D1AC90579Q34545343-7CF4BA5E-0CA7-40E8-87ED-7212BE107AEAQ34550483-1C430E6D-2545-409F-A546-4D297C4B0205Q34635175-AC804807-F5B1-4345-B42F-E3150798E240Q34792547-899C7B1B-CBE6-48EC-AB6B-C1FE727F6BFFQ34994708-F13CD757-0F8A-44DC-B217-3E3068EE5D76Q35210306-4BBF3F06-6C50-42AF-971B-44093D13387EQ35551006-4DD169CC-5A85-4851-B8D0-BC470D97DF2BQ35590828-E5375280-D037-4AF6-83E0-D3796404F56FQ35607051-20F3B7B1-5404-4821-AE4A-F117784251B4Q35642257-FD156945-FB7E-433E-94FB-E4BE6ED68C4BQ35698405-C44FCA3C-2775-49AE-9517-F50BB74CFD3BQ35827510-B76FCD01-9E7E-44F8-BC05-D8B35FEA7F2DQ35827661-DB705FA1-535E-4A19-A0A5-4957230D754DQ35951283-54821406-2AA7-464F-ADCC-375BB71E062BQ35953557-D70AFE80-20DC-4E7C-B3E6-015B686446F2Q35970874-34F26A30-9314-4D92-A573-F5F2CE696138Q36254041-DC8BD735-1867-4737-960F-EF73061E62D8Q36258253-2235D771-56EC-45F4-B1A8-252E5A3A0929Q36388073-0C70DEC0-6989-4B75-842C-B3F191EE4881Q36391044-8C1B8DBE-0C05-4F2F-85C5-CF42F8CABCB2Q36546247-76011132-EDD5-4418-9680-AD174E650CBF
P2860
Sex is a major determinant of CYP3A4 expression in human liver.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Sex is a major determinant of CYP3A4 expression in human liver.
@ast
Sex is a major determinant of CYP3A4 expression in human liver.
@en
Sex is a major determinant of CYP3A4 expression in human liver.
@nl
type
label
Sex is a major determinant of CYP3A4 expression in human liver.
@ast
Sex is a major determinant of CYP3A4 expression in human liver.
@en
Sex is a major determinant of CYP3A4 expression in human liver.
@nl
prefLabel
Sex is a major determinant of CYP3A4 expression in human liver.
@ast
Sex is a major determinant of CYP3A4 expression in human liver.
@en
Sex is a major determinant of CYP3A4 expression in human liver.
@nl
P2093
P2860
P356
P1433
P1476
Sex is a major determinant of CYP3A4 expression in human liver.
@en
P2093
Andreas K Nüssler
Kathrin Klein
Matthias Schwab
Michel Eichelbaum
Oliver Burk
Renzo Wolbold
P2860
P304
P356
10.1002/HEP.1840380424
P407
P577
2003-10-01T00:00:00Z